dc.date.accessioned2022-01-18T19:26:50Z
dc.date.available2022-01-18T19:26:50Z
dc.date.created2022-01-18T19:26:50Z
dc.date.issued2012
dc.identifierhttps://hdl.handle.net/20.500.12866/10922
dc.identifierhttps://doi.org/10.1055/s-0031-1298459
dc.description.abstractTwo new dihydrochalcones, as well as eight known compounds, piperaduncin C, 2,6-dihydroxy-4-methoxydihydrochalcone, 4,2,6-trihydroxy-4-methoxydihydrochalcone, 4-hydroxy-3,5-bis(3-methyl-2- butenyl)-benzoic acid, 3,5-bis(3-methyl-2-butenyl)-4-methoxybenzoic acid, 4-hydroxy-3-(3-methyl-2-butenoyl)-5-(3-methyl-2-butenyl)-benzoic acid, 2,2-dimethyl-8-(3-methyl-2-butenyl)-2H-1-chromene-6-carboxylic acid, and 3-(3,7-dimethyl-2,6-octadienyl)-4-methoxybenzoic acid were isolated from the leaves of Piper dennisii Trelease (Piperaceae), using a bioassay-guided fractionation to determine their antileishmanial potential. Among them, compound 10 exhibited the best antileishmanial activity (IC= 20.8 M) against axenic amastigote forms of Leishmania amazonensis, with low cytotoxicity on murine macrophages. In the intracellular macrophage-infected model, compound 10 proved to be more active (IC= 4.2 M). The chemical structures of compounds 1-10 were established based on the analysis of the spectroscopic data.
dc.languageeng
dc.publisherGeorg Thieme Verlag
dc.relationPlanta Medica
dc.relation1439-0221
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectControlled Study
dc.subjectAnimal Cell
dc.subjectAmastigote
dc.subjectDisease Model
dc.subjectMacrophage
dc.subjectLeishmania
dc.subjectPlant Extract
dc.subjectAmphotericin B
dc.subjectDrug Isolation
dc.subjectMolecular Structure
dc.subjectPlant Leaf
dc.subjectCytotoxicity
dc.subjectDrug Structure
dc.subjectMurinae
dc.subjectAntiprotozoal Agents
dc.subjectIC 50
dc.subjectLeishmania Amazonensis
dc.subjectAntileishmanial Agent
dc.subjectDrug Activity
dc.subjectChalcone Derivative
dc.subjectChalcones
dc.subjectInhibitory Concentration 50
dc.subjectMacrophages Peritoneal
dc.subjectBioassay
dc.subjectFractionation
dc.subjectSpectroscopy
dc.subjectPiperaceae
dc.subjectPiper
dc.subjectChemical Structure
dc.subject22 Dimethyl 8 (3 Methyl 2 Butenyl) 2h 1 Chromene 6 Carboxylic Acid
dc.subject2'6' Dihydroxy 4' Methoxydihydrochalcone
dc.subject3 (3'7' Dimethyl 2'6' Octadienyl) 4 Methoxybenzoic Acid
dc.subject35 Bis(3 Methyl 2 Butenyl) 4 Methoxybenzoic Acid
dc.subject4 Hydroxy 3 (3 Methyl 2 Butenoyl) 5 (3 Methyl 2 Butenyl)Benzoic Acid
dc.subject4 Hydroxy 35 Bis(3 Methyl 2 Butenyl)Benzoic Acid
dc.subject42'6' Trihydroxy 4' Methoxydihydrochalcone
dc.subjectAntileishmanial Activities
dc.subjectBenzoic Acid Derivative
dc.subjectBenzoic Acids
dc.subjectDihydrochalcones
dc.subjectDrug Evaluation Preclinical
dc.subjectPiper (Plant)
dc.subjectPiper Dennisii|Piperaduncin C
dc.titleDihydrochalcones and benzoic acid derivatives from piper dennisii
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución